Overcoming Complex Multi-Strain & Novel Organism Manufacturing Challenges to Enable Scalable Therapeutic Production
- Addressing fermentation, stabilization and scale-up challenges for non-traditional bacterial taxa to ensure consistent large-scale therapeutic manufacturing
- Designing processes for multi-strain consortia with robust quality control frameworks to manage complexity, variability and production costs effectively
- Implementing early manufacturing strategies aligned with clinical development to avoid delays and ensure readiness for late-stage trials